Sun pharmaceutical industries limited fda inspections. Remain optimistic of sun pharma halol unit issue resolution. An analysis of recent cder observation warning letter data. The us fda issued the notice on tuesday with nine inspectional observations after an onsite inspection of sun pharmas halol facility in gujarat. The warning to sun pharma is the latest in a series of fda actions over the past year against drug manufacturing plants in india, which supply about 40 per cent of the medicines sold in the united. Sun house, 201 b1, western express highway, goregaon e, mumbai 400063 for further updates and specific queries, please visit. Global sales of branded generic drugs are expected to progress at 8% cagr through 2029, but the us and europe are not set to drive this growth.
Fda slaps sun pharma with warning letter on indian plant. Sun pharma has received a warning letter from the us drug regulator usfda over violation of manufacturing norms in its facility at halol in gujarat. The inspection lasted 12 days from the 8 th september to the 19 th september, 2014 while the warning letter was issued only in december, 2015 a complete year later as there were. Gmp drug warning letters issued in calendar year 2015 data. If you need help accessing information in different file formats, see instructions for downloading. Sun pharma gets usfda warning letter on halol facility. Dec 21, 2015 fda slaps sun pharma with warning letter on indian plant. Indias largest drugmaker sun pharma gets warning letter from. Sun pharma receives warning letter for halol facilitydecember 19, 2015. New fda warning letter, form 483 for two indian companies raps. Thanks to a slew of quality control problems at one of its key generic manufacturing plants, indias largest drug maker has been under supply restrictions. New fda warning letter, form 483 for two indian companies. Thousands of executives in these and allied organisations find the pharma letter a necessary read to keep them the first to know about current news and events, written whilst the news is fresh and has the greatest impact on commercial decisions. A year after facing insider trading claims, sun pharma now must fight charges it fired two former employees for refusing to market its meds offlabel.
We acknowledge receipt of your additional correspondence of december 12, 2014. The fda flagged issues with the companys laboratory records. Sun pharma announces divestment of us manufacturing unitdecember 14, 2015. The form 483 notice sent by us food and drug administration to sun pharma could shave off indias biggest drugmakers fy18 eps by 26%, analysts estimate. Fda issues warning letter to api manufacturer biopharm. Indias largest drugmaker said on saturday it had received a letter from the fda and. Us fda conducted its first inspection of the facility in 2014 and another in december 2015. Batch records indicated significant deviations that the quality unit failed to investigate. Fda warning letter hits sun pharma for hiding batch failures. Learn about the types of warning letters on fdas website. Incomplete batch documentation falsification of data on batch documentation datatest. Nomura recently, sun pharma announced that the us food and drug administration had inspected the formulation facility between november 17 and december 1 and issued a form 483. The fda in its letter dated january 15, 2017 to fleming laboratories, a pharma company in the business of manufacturing and supply of high quality generic active pharmaceutical ingredients apis to the global pharmaceutical industry observed that it has completed an evaluation of the firms corrective actions in response to its warning letter.
Caraco pharmaceuticals, a subsidiary of sun pharma, tuesday said it has received a warning letter from us food and drug administration, or, fda, over the companys manufacturing facility. We may also refuse admission of articles manufactured at sun pharmaceutical industries ltd. Performance qualification laf laminar air flow pharma editor july 29, 2017. Sun has been working to address problems at the halol facility since 2015 when it was issued with a warning letter by the us fda. Film coating process of tablet in pharmaceutical manufacturing. Sun pharmaceutical industries shares sink on fda warning letter. Food and drug administration has pulled up a former sun pharmaceutical sun. The violation, such as poor manufacturing practices, problems with claims for what a product can do, or. The problem dates back to 2014, when sun first received an fda form 483 for the site, followed shortly thereafter with a formal warning letter, citing serious sterility concerns. By pharma news dcat publisher january 15, 2016 the us food and drug administration fda has posted a warning letter on its website to zhejiang hisun pharmaceutical co. View sun pharmaceutical industries limiteds fda inspection, warning letter, form 483 observation details related to gmp quality systems on. Rapid mixer granulator is a multipurpose processer equally suitable for high speed dispersion of dry powders, aqueous or solvent granulation, and effervescent products and.
Corporate participants dilip shanghvi managing director, sun. Apr 21, 2017 sun pharmas stock fell as much as 3 percent to 636. By pharma news dcat publisher january 5, 2016 the us food and drug administration fda has issued a warning letter to sun pharmaceutical industries ltd. The average time to warning letter issuance for all drug manufacturer categories, including compounding pharmacies outsourcing facilities, exceeded 12 months in 1hfy2016. Tracking the sun pharma halol plant us fda inspection. The fda has issued a warning letter to sun pharmaceutical for its plant in halol, india, a facility. Sun pharmaceuticals factory in halol, in the western indian state of gujarat, received a warning letter from the fda, the latest setback for indias pharmaceutical companies. The fda said in its warning letter from earlier this month, which comes as sun has also been issued an import alert over cgmp issues, that sun is missing fundamental raw data and information necessary to document its analyses. May 26, 2017 clearance of the warning letter may require another inspection, sun pharmas shanghvi said on the call. The fda has issued a warning letter to sun pharmaceutical for its. Press release sun pharma receives warning letter for halol. Sun pharma shares fall 7% after fda warning financial times. Sun pharma receives warning letter for halol facility mumbai, december 19, 2015.
Clearance of the warning letter may require another inspection, sun pharmas shanghvi said on the call. Data integrity deficiencies january, 2016 the tabulation on pages 454 include full text of data integrity deficiencies identified in fda drug gmp warning letters issued in calendar year 2015. Us fda issues sun with form 483 after dadra plant inspection. Fda finds incomplete lab records at sun pharma plant. Sun pharma hit with warning letter over data issues. Dilip shangvi, managing director, expressed consternation that the warning letter, received on friday, had been sent so long after the september 2014 inspection, as he said sun had been working. The neardoubling of time between inspection and warning letters issued to sites outside the u. Warning letter for halol facility call transcript 06. The pharma letter provides accurate, unbiased business information on the worldwide pharmaceutical, generic and biotechnology industries. Indias largest drug maker sun pharma has received a warning letter from the us fda for manufacturing lapses at its facility in halol. Matters described in fda warning letters may have been subject to subsequent interaction between fda and the letter recipient that may.
Sun pharma and ranbaxy to merge, create giant pharma co we had managed to get our hands on the warning letter issued by us fda late last year. Links to the warning letter on the fda website are included as well as information regarding imposition of import alerts posted on the fda website. Sun pharma warns new normal will push down its sales next. Us fda warns sun pharma for violating manufacturing standards. Last february, the agency placed the firm on import alert. The letter also raised another issue that putz had discussed with caraco managementthe varying sizes of the tablets it producedinstructing caraco to resolve. Warning letter cgmpactive pharmaceutical ingredients apis 1231 2015.
Sun pharmas stock fell as much as 3 percent to 636. Laminar air flow laf work station is capable of maintaining a particulate free work area even when operated in an uncontrolled environment. We acknowledge receipt of your additional correspondence. The firm also strayed from its batch manufacturing instructions, allowing a bulk batch that was outofspecification to get passing results for viscosity and density, the agency said.
View strides shasun limiteds fda inspection, warning letter, form 483 observation details related to gmp quality systems on. Sun pharma gets warning letter from usfda for key facility at. Sun had expected halol regain compliance last year. Branded generics forecast to double revenues, with us and europe left behind. Fdas warning to sal pharma comes roughly 10 months after the agency inspected the companys hyderabad, india facility in june and july 2016. In december 2016 the fda sent sun a warning letter about nine violations at its manufacturing plant in halol.
When the us fda finds that a firm has significantly violated fda regulations e. Dec 21, 2015 sun pharma shares fall 7% after fda warning. Sun pharma gets warning letter from usfda newsgram. Cardinal predicts api industry should be able to work.
The warning letter from the usfda will add to the troubles being faced by sun pharma, which has also been weighed down by the integration process with ranbaxy laboratories. Ns drug factory for knowingly releasing 27 lots of. Sun pharma gets us fda warning for manufacturing lapses. Sep 10, 20 when the us fda finds that a firm has significantly violated fda regulations e. Sun pharma announces us fda filing acceptance of biologics. Dec 19, 2015 dilip shangvi, managing director, expressed consternation that the warning letter, received on friday, had been sent so long after the september 2014 inspection, as he said sun had been working. Fda issued a warning letter on may 27, 2015 to vuab pharma, a manufacturer of apis and soliddosage forms located in the czech republic, for cgmp deviations including the distribution of contaminated apis and inadequate data control. The fda replied to caracos letter on december 22, 2008, characterizing caracos response to the warning letter as positive. Jan 05, 2016 by pharma news dcat publisher january 5, 2016 the us food and drug administration fda has issued a warning letter to sun pharmaceutical industries ltd. Cardinal tips api supply chain to weather impact of coronavirus.
735 66 621 305 1041 317 657 698 1350 340 1367 350 434 881 1559 106 1331 1523 842 901 1417 1437 996 231 992 1431 1002 686 653 1373 1272